Over 24 lakh pregnant women in India were found to be colonized with group B Streptococcus (GBS) bacteria in 2015 found a new study published in Clinical Infectious Diseases journal. These GBS bacteria accounted for about 13,000 infant deaths this year, the highest in the world.
GBS is a major, yet preventable, type of bacterial infection that can be found in a pregnant woman's vagina or rectum and is responsible for maternal and infant ill-health globally.
Group B Streptococcus Causes Maternal And Infant Ill Health
Group B Streptococcus is present among pregnant women in all regions of the world, with an average of 18% of pregnant women worldwide carrying the bacteria.
Advertisement
‘Immunising expectant mother is the only way to reduce the number of maternal and child deaths associated GBS infection. Early-onset GBS disease in newborns is the leading cause of infant deaths among the Indian population.’
Tweet it Now
The researchers conservatively estimate that out of 410,000 GBS cases every year; there will be at least 147,000 stillbirths and infant deaths globally.
Emphasising the need for a maternal GBS vaccine, the team, led by London School of Hygiene & Tropical Medicine, revealed that Nigeria with 8,000 infant GBS-related deaths ranked second, followed by Ethiopia (4,000), the Democratic Republic of the Congo (4,000) and Pakistan (3,000).
![Presence Of Group B Streptococcus In Pregnant Women Can Cause Preterm Birth]( "Presence Of Group B Streptococcus In Pregnant Women Can Cause Preterm Birth")
The membrane-bound vesicles formed by bacteria can attack and invade the host tissue.
When it comes to infant GBS disease cases, India again topped with 31,000 infant disease cases. China was second with 25,000 cases, followed by Nigeria (22,000), the Democratic Republic of the Congo (16,000) and Egypt (14,000).
"Antibiotics currently prevent an estimated 29,000 cases of early-onset GBS disease per year, almost all in high-income settings. However, this approach may be difficult in low-income settings where many births take place at home, and laboratory capacity for screening for GBS is limited," said Joy Lawn, Professor at London School of Hygiene & Tropical Medicine.
The GBS bacteria was found to be present in an average of 18 percent of pregnant women worldwide carrying the bacteria -- ranging from 11 percent in eastern Asia to 35 percent in the Caribbean -- totaling 21.7 million in 195 countries.
The top five countries by numbers (to nearest 100) of pregnant women colonised were: India (2,466,500) China (1,934,900), Nigeria (1,060,000), the US (942,800) and Indonesia (799,100).
"In addition, giving antibiotics to 21.7 million women may contribute to antimicrobial resistance -- a major global health crisis," Lawn added.
Despite being home to only 13 percent of the world's population, Africa had the highest burden, with 54 percent of estimated cases and 65 percent of still-births and infant deaths, said the study published in the journal Clinical Infectious Diseases.
The study urged for the development of an effective GBS vaccine, saying that immunizing expectant mothers is a potentially ground-breaking approach that could dramatically reduce the number of maternal and child deaths.
According to the researchers, a maternal GBS vaccine, which is just 80 percent effective and is able to reach at least 90 percent of women, could potentially prevent 231,000 infant and maternal GBS cases globally.
"Even if antibiotics were given to all pregnant women identified through screening strategies, they target mainly early-onset GBS disease in newborns, not GBS disease in pregnant women, GBS disease before delivery causing stillbirth, or GBS disease in infants more than a couple of days old", explained Anna Seale, Associate Professor at the varsity.
Although several vaccines to prevent GBS are in development, none is currently available. Current GBS prevention focuses on giving antibiotics to women in labor, aiming to reduce disease in infants at delivery.
Only "a maternal GBS vaccine could prevent many more cases and deaths worldwide," Seale added.
Source: IANS
Presence Of Group B Streptococcus In Pregnant Women Can Cause Preterm Birth
The membrane-bound vesicles formed by bacteria can attack and invade the host tissue.
Advertisement
When it comes to infant GBS disease cases, India again topped with 31,000 infant disease cases. China was second with 25,000 cases, followed by Nigeria (22,000), the Democratic Republic of the Congo (16,000) and Egypt (14,000).
"Antibiotics currently prevent an estimated 29,000 cases of early-onset GBS disease per year, almost all in high-income settings. However, this approach may be difficult in low-income settings where many births take place at home, and laboratory capacity for screening for GBS is limited," said Joy Lawn, Professor at London School of Hygiene & Tropical Medicine.
The GBS bacteria was found to be present in an average of 18 percent of pregnant women worldwide carrying the bacteria -- ranging from 11 percent in eastern Asia to 35 percent in the Caribbean -- totaling 21.7 million in 195 countries.
The top five countries by numbers (to nearest 100) of pregnant women colonised were: India (2,466,500) China (1,934,900), Nigeria (1,060,000), the US (942,800) and Indonesia (799,100).
"In addition, giving antibiotics to 21.7 million women may contribute to antimicrobial resistance -- a major global health crisis," Lawn added.
Despite being home to only 13 percent of the world's population, Africa had the highest burden, with 54 percent of estimated cases and 65 percent of still-births and infant deaths, said the study published in the journal Clinical Infectious Diseases.
The study urged for the development of an effective GBS vaccine, saying that immunizing expectant mothers is a potentially ground-breaking approach that could dramatically reduce the number of maternal and child deaths.
According to the researchers, a maternal GBS vaccine, which is just 80 percent effective and is able to reach at least 90 percent of women, could potentially prevent 231,000 infant and maternal GBS cases globally.
"Even if antibiotics were given to all pregnant women identified through screening strategies, they target mainly early-onset GBS disease in newborns, not GBS disease in pregnant women, GBS disease before delivery causing stillbirth, or GBS disease in infants more than a couple of days old", explained Anna Seale, Associate Professor at the varsity.
Although several vaccines to prevent GBS are in development, none is currently available. Current GBS prevention focuses on giving antibiotics to women in labor, aiming to reduce disease in infants at delivery.
Only "a maternal GBS vaccine could prevent many more cases and deaths worldwide," Seale added.
Source: IANS
Incidence of Group B Streptococcus Rises Among Newborns
A major cause of serious infectious diseases including sepsis, meningitis and pneumonia is the Group B streptococcus.
Advertisement
 New Discovery Could Lead to Vaccine Against Flesh Eating BacteriaPatterns in the outer protein coat of group A Streptococcus bacteria have been uncovered by University of California San Diego researchers. | Advertisement
|
Advertisement
Recommended Readings
Latest Indian Health News
Nine-year-old, son of a recent Nipah victim, among discharges; Kozhikode authorities flagged outbreak mid-September.
Lifestyle factors contribute to Alzheimer's. Low social engagement, sleep, physical activity, and diet increase the risk. Staying healthy can reduce these factors.
India excels in tackling HIV, tuberculosis (TB), and malaria, especially in TB elimination, surpassing global progress
The data offers a wealth of information on suicide factors, warning signs, available resources, and dedicated prevention helplines, among other crucial details.
India's G20 leadership aims to bolster digital health initiatives and enhance healthcare equity through greater integration of telemedicine and artificial intelligence tools.
